Novel compound heterozygous mutations in CYP1B1 identified in a Chinese family with developmental glaucoma.

Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: MEDLINE

Original Publication: Athens, Greece : D. A. Spandidos

Family* ; Genetic Predisposition to Disease* ; Heterozygote* ; Mutation*; Cytochrome P-450 CYP1B1/*genetics ; Glaucoma/*diagnosis ; Glaucoma/*genetics; Adolescent ; Alleles ; Amino Acid Substitution ; China ; Cytochrome P-450 CYP1B1/chemistry ; DNA Mutational Analysis ; Genetic Association Studies ; Humans ; Intraocular Pressure ; Male ; Models, Molecular ; Pedigree ; Phenotype ; Structure-Activity Relationship ; Vision Tests ; Visual Acuity

Developmental glaucoma, a subset of glaucoma, is associated with trabeculodysgenesis and/or anterior segment dysgenesis. It is one of the major causes of childhood blindness. Understanding its genetic background is important to diagnose, and identify potential therapeutic targets, of this disease. The present study aimed to detect the molecular origin of developmental glaucoma in a Chinese pedigree and its association with glaucomatous phenotypes. A three‑generation pedigree with developmental glaucoma was analyzed in the current study; a thorough ocular examination was performed on the proband and other individuals in the family. Genomic DNA was extracted from the peripheral blood of each individual, and possible disease‑causing genes were screened for mutations using a candidate gene panel. Exons and adjacent regions of the target genes were captured and enriched by probe hybridization. The enriched genes were sequenced on an Illumina high‑throughput sequencer. Variations were verified in other family members using Sanger sequencing. Disease causing mutations were analyzed by comparing the sequences and the structures of wild‑type and mutated cytochrome P450 family 1 subfamily B member 1 ( CYP1B1 ) proteins using PyMOL software. The proband was diagnosed with developmental glaucoma and his parents and other relatives were asymptomatic. Novel compound heterozygous mutations, c.3G>A (p.M1I) and c.1310C>T (p.P437L), in CYP1B1 were detected in the proband, with the former inherited from his father and the latter from his mother. The c.3G>A (p.M1I) change is a novel mutation that disrupts the ATG start codon in exon one of CYP1B1 and therefore interferes with the translation start site. In conclusion, the findings of the present study suggested that the aforementioned compound heterozygous mutations in CYP1B1 may have caused developmental glaucoma in this Chinese family. The c.3G>A mutation in CYP1B1 is a novel mutation, and this study expands the gene mutation spectrum of CYP1B1 .

Exp Eye Res. 2011 Nov;93(5):572-9. (PMID: 21854771)
Genomics. 1995 Nov 20;30(2):171-7. (PMID: 8586416)
J Glaucoma. 2010 Mar;19(3):176-82. (PMID: 19528825)
Mol Cell Biol. 2013 Nov;33(21):4225-40. (PMID: 23979599)
Mol Vis. 2009;15:417-31. (PMID: 19234632)
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8301-5. (PMID: 2236042)
Front Aging Neurosci. 2021 Jul 08;13:696778. (PMID: 34305573)
Biomed Res Int. 2015;2015:781294. (PMID: 26451378)
J Med Genet. 2003 Jan;40(1):e9. (PMID: 12525557)
Mol Vis. 2019 Feb 22;25:144-154. (PMID: 30820150)
Exp Eye Res. 2017 Feb;155:91-98. (PMID: 28153738)
Am J Ophthalmol. 2006 Dec;142(6):993-1004. (PMID: 17157584)
Arch Ophthalmol. 2008 Oct;126(10):1443-7. (PMID: 18852424)
Hum Mol Genet. 1996 Aug;5(8):1199-203. (PMID: 8842741)
Mol Vis. 2004 Sep 30;10:696-702. (PMID: 15475877)
Pharmacogenet Genomics. 2008 Aug;18(8):665-76. (PMID: 18622259)
Eye (Lond). 2000 Jun;14 ( Pt 3B):422-8. (PMID: 11026969)
Int J Ophthalmol. 2019 Jan 18;12(1):8-15. (PMID: 30662834)
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1820-7. (PMID: 12036985)
Surv Ophthalmol. 1983 Jul-Aug;28(1):1-19. (PMID: 6353647)
J Curr Glaucoma Pract. 2013 Jan-Apr;7(1):25-35. (PMID: 26997777)
Ophthalmol Clin North Am. 2003 Dec;16(4):543-54, vi. (PMID: 14740995)
Trans Am Ophthalmol Soc. 2006;104:183-95. (PMID: 17471339)
J Pediatr Genet. 2017 Dec;6(4):205-214. (PMID: 29142762)
Middle East Afr J Ophthalmol. 2011 Jan;18(1):7-16. (PMID: 21572728)
Biophys J. 2006 Dec 15;91(12):4329-39. (PMID: 16963504)
Am J Hum Genet. 1998 Mar;62(3):573-84. (PMID: 9497261)
J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):60-7. (PMID: 26005555)
Mol Vis. 2011;17:2911-9. (PMID: 22128238)
Hum Mol Genet. 2009 Oct 15;18(20):3969-77. (PMID: 19656777)
Annu Rev Pharmacol Toxicol. 2008;48:333-58. (PMID: 17914928)
Biomedicines. 2021 Jul 13;9(7):. (PMID: 34356876)
J Curr Glaucoma Pract. 2013 May-Aug;7(2):66-84. (PMID: 26997785)
Genet Test Mol Biomarkers. 2019 Dec;23(12):850-856. (PMID: 31821093)
J Biol Chem. 2011 Feb 18;286(7):5736-43. (PMID: 21147782)
Vet Pathol. 2015 Mar;52(2):397-403. (PMID: 24879660)

Keywords: compound heterozygous mutations; cytochrome P450 family 1 subfamily B member 1; developmental glaucoma

EC 1.14.14.1 (CYP1B1 protein, human)
EC 1.14.14.1 (Cytochrome P-450 CYP1B1)

Date Created: 20210916 Date Completed: 20220117 Latest Revision: 20220121

20250114

PMC8764508

10.3892/mmr.2021.12443

34528698